<seo title="Biogen" metakeywords="biogen impact pharmaceutical,biogen products,pharmaceutical industry biogen,industry biogen products" metadescription="Biogen was founded in 1978 and is headquartered in Cambridge, Massachusetts.Biogen has operations in more than 30 countries and employs more than 7,000 people worldwide." />
===Introduction to Biogen===

Biogen is a global biotechnology company that is focused on discovering, developing, manufacturing, and delivering innovative therapies to treat serious neurological, autoimmune, and rare diseases. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. Biogen has operations in more than 30 countries and employs more than 7,000 people worldwide. The company’s mission is to use cutting-edge science to develop treatments that improve the lives of patients with serious neurological, autoimmune, and rare diseases.
===History of Biogen===

Biogen was founded in 1978 by two scientists, Walter Gilbert and Phillip Sharp. The company was initially focused on developing treatments for cancer and other diseases. In the early 1980s, Biogen began to focus on developing treatments for neurological and autoimmune diseases. In 1986, the company launched its first product, Avonex, a treatment for multiple sclerosis. Since then, Biogen has developed a number of treatments for neurological and autoimmune diseases, including Tecfidera, a treatment for multiple sclerosis, and Spinraza, a treatment for spinal muscular atrophy.
===Financial Performance of Biogen===

Biogen has had a strong [[Financial Performance|financial performance]] over the past few years. In 2020, the company reported total revenues of $14.2 billion, an increase of 8% from the previous year. The company’s [[Net Income|net income]] was $3.3 billion, an increase of 11% from the previous year. The company’s strong financial performance is due to the success of its products and services.
===Biogen’s Products and Services===

Biogen’s products and services are focused on treating neurological, autoimmune, and rare diseases. The company’s products include treatments for multiple sclerosis, spinal muscular atrophy, and Alzheimer’s disease. The company also offers services such as clinical trials, research and development, and manufacturing.
===Biogen’s Impact on the Pharmaceutical Industry===

Biogen has had a significant impact on the pharmaceutical industry. The company’s products and services have helped to improve the lives of patients with serious neurological, autoimmune, and rare diseases. The company’s success has also helped to spur innovation in the pharmaceutical industry, as other companies have sought to develop treatments for neurological and autoimmune diseases.
===Conclusion===

Biogen is a global biotechnology company that is focused on discovering, developing, manufacturing, and delivering innovative therapies to treat serious neurological, autoimmune, and rare diseases. The company has had a strong financial performance over the past few years and has had a significant impact on the pharmaceutical industry. Biogen’s products and services have helped to improve the lives of patients with serious neurological, autoimmune, and rare diseases